Abstract
Objectives To investigate how ethnicity and other sociodemographic, work, and physical health factors are related to mental health in UK healthcare and ancillary workers (HCWs), and how structural inequities in these factors may contribute to differences in mental health by ethnicity.
Design Cross-sectional analysis of baseline data from the UK-REACH national cohort study
Setting HCWs across UK healthcare settings.
Participants 11,695 HCWs working between December 2020-March 2021.
Main outcome measures Anxiety or depression symptoms (4-item Patient Health Questionnaire, cut-off >3), and Post-Traumatic Stress Disorder (PTSD) symptoms (3-item civilian PTSD Checklist, cut-off >5).
Results Asian, Black, Mixed/multiple and Other ethnic groups had greater odds of PTSD than the White ethnic group. Differences in anxiety/depression were less pronounced. Younger, female HCWs, and those who were not doctors had increased odds of symptoms of both PTSD and anxiety/depression. Ethnic minority HCWs were more likely to experience the following work factors that were also associated with mental ill-health: workplace discrimination, feeling insecure in raising workplace concerns, seeing more patients with COVID-19, reporting lack of access to personal protective equipment (PPE), and working longer hours and night shifts. Ethnic minority HCWs were also more likely to live in a deprived area and have experienced bereavement due to COVID-19. After adjusting for sociodemographic and work factors, ethnic differences in PTSD were less pronounced and ethnic minority HCWs had lower odds of anxiety/depression compared to White HCWs.
Conclusions Ethnic minority HCWs were more likely to experience PTSD and disproportionately experienced work and sociodemographic factors associated with PTSD, anxiety and depression. These findings could help inform future work to develop workplace strategies to safeguard HCWs’ mental health. This will only be possible with adequate investment in staff recruitment and retention, alongside concerted efforts to address inequities due to structural discrimination.
What is already known on this topic
The pandemic is placing healthcare workers under immense pressure, and there is currently a mental health crisis amongst NHS staff
Ethnic inequities in health outcomes are driven by structural discrimination, which occurs inside and outside the workplace
Investigating ethnic inequities in the mental health of healthcare workers requires large diverse studies, of which few exist
What this study adds
In UK-REACH (N=11,695), ethnic minority staff had higher odds of Post-Traumatic Stress Disorder symptoms; we report many other factors associated with mental-ill health, including those experienced disproportionately by ethnic minority staff, such as workplace discrimination, contact with more patients with COVID-19, and bereavement due to COVID-19
These findings underline the moral and practical need to care for staff mental health and wellbeing, which includes tackling structural inequities in the workplace; improving staff mental health may also reduce workforce understaffing due to absence and attrition
Competing Interest Statement
SC is Deputy Medical Director of the General Medical Council, UK Honorary Professor, University of Leicester. MDT receives funding from GSK for collaborative research projects outside of the submitted work. KK is Director of the University of Leicester Centre for Black Minority Ethnic Health, Trustee of the South Asian Health Foundation and Chair of the Ethnicity Subgroup of the UK Government Scientific Advisory Group for Emergencies (SAGE). MP reports grants from Sanofi, grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work.
Clinical Protocols
http://dx.doi.org/10.1136/bmjopen-2021-050647
Funding Statement
UK-REACH is supported by a grant (MR/V027549/1) from the MRC-UK Research and Innovation (UKRI) and the Department of Health and Social Care through the National Institute for Health Research (NIHR) rapid response panel to tackle COVID-19. Core funding was also provided by NIHR Biomedical Research Centres. ALG was funded by internal fellowships at the University of Leicester from the Wellcome Trust Institutional Strategic Support Fund (204801/Z/16/Z) and the BHF Accelerator Award (AA/18/3/ 34220). LBN is supported by an Academy of Medical Sciences Springboard Award (SBF005\1047). CJ was funded by a Medical Research Council Clinical Research Training Fellowship (MR/P00167X/1). CAM is an NIHR Academic Clinical Fellow (ACF-2018-11-004). MDT holds a Wellcome Trust Investigator Award (WT 202849/Z/ 16/Z) and an NIHR Senior Investigator Award. KW is funded through an NIHR Career Development Fellowship (CDF-2017-10-008). MP is funded by an NIHR Development and Skills Enhancement Award and with KK, also acknowledges support from the NIHR Leicester BRC and with KK and LJG, acknowledges support from NIHR ARC East Midlands. LBN is supported by the Academy of Medical Sciences (SBF005/1047). This work is carried out with the support of BREATHE - the Health Data Research Hub for Respiratory Health (MC_PC_19004) funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Health Research Authority (Brighton and Sussex Research Ethics Committee; ethics reference: 20/HRA/4718). All participants gave their informed consent via an online consent process.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵+ Manish Pareek (Chief investigator), Laura J Gray (University of Leicester), Laura Nellums (University of Nottingham), Anna L Guyatt (University of Leicester), Catherine John (University of Leicester), I Chris McManus (University College London), Katherine Woolf (University College London), Ibrahim Akubakar (University College London), Amit Gupta (Oxford University Hospitals), Keith R Abrams (University of York), Martin D Tobin (University of Leicester), Louise V Wain (University of Leicester), Sue Carr (University Hospital Leicester), Edward Dove (University of Edinburgh), Kamlesh Khunti (University of Leicester), David Ford (University of Swansea), Robert Free (University of Leicester).
Role of the funding source The funding source was not involved in study design, data collection or analysis, interpretation, or writing of the report.
Data sharing Deidentified participant data are available via a system of managed access, to access data or samples produced by the UK-REACH study please contact uk-reach{at}leicester.ac.uk to discuss your request. The protocol for the UK-REACH longitudinal cohort study is available at: http://dx.doi.org/10.1136/bmjopen-2021-050647, and a Data Dictionary of the baseline questionnaire data is available at: https://uk-reach.org/main/data-dictionary/.
Competing interests SC is Deputy Medical Director of the General Medical Council, UK Honorary Professor, University of Leicester. MDT receives funding from GSK for collaborative research projects outside of the submitted work. KK is Director of the University of Leicester Centre for Black Minority Ethnic Health, Trustee of the South Asian Health Foundation and Chair of the Ethnicity Subgroup of the UK Government Scientific Advisory Group for Emergencies (SAGE). MP reports grants from Sanofi, grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work.
Data Availability
Deidentified participant data are available via a system of managed access, to access data or samples produced by the UK-REACH study please contact uk-reach@leicester.ac.uk to discuss your request. The protocol for the UK-REACH longitudinal cohort study is available at: http://dx.doi.org/10.1136/bmjopen-2021-050647, and a Data Dictionary of the baseline questionnaire data is available at: https://uk-reach.org/main/data-dictionary/.
